>>Description of the research protocol "1615R2132"

A Multicenter, randomized, double-blind, parallel-group, clinical study of S-649266 compared to Meropenem for the treatment of hospital-acquired bacterial pneumonia, ventilator-associated bacterial pneumonia, or healthcare-associated bacterial pneumonia c
Phase III study| Status : Ongoing (but closed to recruitment)

Additional details

Indication (or studied pathology) : Pneumonie
Brugmann identifier : 1615R2132
EudraCT identifier : 2016-003020-23


Involved department : Infectiology
Principal investigator : Clevenbergh
Sponsor : Shionogi
Contact : Clinical Research Unit

>This protocol was approved by the Erasme ethics committee.